SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 3-DIMENSIONAL PHARMACEUTICALS (DDDP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (31)10/8/2001 8:09:48 PM
From: Miljenko Zuanic  Read Replies (1) of 146
 
<<``Since signing the agreement in December 2000, we have worked very closely with the Centocor team and are currently evaluating a full panel of thrombin inhibitors to determine which new product candidates to further develop. We see this milestone as a further validation of 3DP's technologies and expertise and look forward to a productive continuing relationship.''>>

So, for what are this 4 millions milestone? Anyone listen today their presentation at UBS W.G>?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News